Ghazala Muteeb, Manar T El-Morsy, Mustafa Ali Abo-Taleb, Salma K Mohamed, Doaa S R Khafaga
{"title":"Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems.","authors":"Ghazala Muteeb, Manar T El-Morsy, Mustafa Ali Abo-Taleb, Salma K Mohamed, Doaa S R Khafaga","doi":"10.3390/pharmaceutics17050673","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is an aggressive and prevalent liver cancer with a poor prognosis. Nanotechnology combined with natural products has emerged as a promising strategy to enhance HCC treatment efficacy. This review assesses the current literature on the application of nanotechnology in delivering natural products for HCC therapy. A comprehensive search was conducted in PubMed, Science Direct, Web of Science, and Google Scholar to identify relevant studies published up to the present articles focusing on nanotechnology-based drug delivery systems using natural products for HCC therapy, including different nanoparticle (NP) formulations and therapeutic interventions, were included. Natural products with anticancer properties have been encapsulated using various nanocarriers such as liposomes, polymeric nanoparticles, and quantum dots, which have improved drug stability, prolonged circulation time, and enhanced targeted delivery to HCC cells. These advancements have led to increased therapeutic efficacy and reduced side effects. Additionally, combining multiple natural products or integrating them with conventional therapies via nanocarriers enables personalized treatment approaches based on patient characteristics and molecular profiles. The integration of nanotechnology with natural products shows great potential for improving HCC treatment outcomes, representing a significant advancement in precision medicine for liver cancer and paving the way for more effective and personalized therapeutic strategies.</p>","PeriodicalId":19894,"journal":{"name":"Pharmaceutics","volume":"17 5","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12114929/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/pharmaceutics17050673","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Hepatocellular carcinoma (HCC) is an aggressive and prevalent liver cancer with a poor prognosis. Nanotechnology combined with natural products has emerged as a promising strategy to enhance HCC treatment efficacy. This review assesses the current literature on the application of nanotechnology in delivering natural products for HCC therapy. A comprehensive search was conducted in PubMed, Science Direct, Web of Science, and Google Scholar to identify relevant studies published up to the present articles focusing on nanotechnology-based drug delivery systems using natural products for HCC therapy, including different nanoparticle (NP) formulations and therapeutic interventions, were included. Natural products with anticancer properties have been encapsulated using various nanocarriers such as liposomes, polymeric nanoparticles, and quantum dots, which have improved drug stability, prolonged circulation time, and enhanced targeted delivery to HCC cells. These advancements have led to increased therapeutic efficacy and reduced side effects. Additionally, combining multiple natural products or integrating them with conventional therapies via nanocarriers enables personalized treatment approaches based on patient characteristics and molecular profiles. The integration of nanotechnology with natural products shows great potential for improving HCC treatment outcomes, representing a significant advancement in precision medicine for liver cancer and paving the way for more effective and personalized therapeutic strategies.
肝细胞癌(HCC)是一种侵袭性和普遍存在的肝癌,预后较差。纳米技术与天然产物结合已成为提高HCC治疗效果的一种有前景的策略。这篇综述评估了目前关于纳米技术在HCC治疗中提供天然产物的应用的文献。我们在PubMed、Science Direct、Web of Science和b谷歌Scholar上进行了全面的搜索,以确定迄今为止发表的相关研究,这些研究集中在基于纳米技术的药物传递系统中,使用天然产物治疗HCC,包括不同的纳米颗粒(NP)配方和治疗干预措施。具有抗癌特性的天然产物已被各种纳米载体(如脂质体、聚合纳米颗粒和量子点)包裹,这些纳米载体提高了药物稳定性,延长了循环时间,并增强了对HCC细胞的靶向递送。这些进步提高了治疗效果,减少了副作用。此外,结合多种天然产物或通过纳米载体将其与传统疗法相结合,可以实现基于患者特征和分子谱的个性化治疗方法。纳米技术与天然产物的结合显示出改善HCC治疗结果的巨大潜力,代表了肝癌精准医学的重大进步,并为更有效和个性化的治疗策略铺平了道路。
PharmaceuticsPharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.90
自引率
11.10%
发文量
2379
审稿时长
16.41 days
期刊介绍:
Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications, and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.